Crinetics Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
6055 Lusk Blvd, San Diego, California, 9...Phone Number
(858) 450-6464Website
www.crinetics.comRevenue
$18.1 MillionStock Symbol
CRNXIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
6
1
1
1
2
About Crinetics Pharmaceuticals
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. Were here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure were solving real problems for them. And we build value in the company for investors by filling real market needs. Whatever brought you here, welcome.Explore more
Crinetics Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Crinetics Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Crinetics Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Crinetics Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Crinetics Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Crinetics Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Crinetics Pharmaceuticals recently announced quarterly report
Check out if Crinetics Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Crinetics Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Crinetics Pharmaceuticals has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Crinetics Pharmaceuticals
Compare insights from companies similar to Crinetics Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Crinetics Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Crinetics Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals financials insights
Gather financial insights about Crinetics Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$100M
Crinetics Pharmaceuticals Tech Stack
A closer look at the technologies used by Crinetics Pharmaceuticals
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Hiring Plans
Hiring Plans
Crinetics Pharmaceuticals News & Media
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
Data from up to two years of treatment in PATHFNDR-1 and PATHFNDR-2 open-label extension studies show PALSONIFY maintained lower IGF-1 levels and stable symptomsCrinetics Pharmaceuticals (CRNX) is One of the Best AI Driven Biotech Stocks, Here is Why
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 10 best AI driven biotech stocks to invest in. As of the June 5 close, Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) had a strongly bullish consensus sentiment. Based on a 1-year target price of $88.14, the stock offers an upside potential of more than 167%% at the prevailing level. […]Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities
Everyday Advocacy provides people living with endocrine and endocrine-related conditions with education, support, and tools to facilitate more impactful healthcare team interactionsCrinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations
Oral presentation features open label extension PALSONIFY™ (paltusotine) data, reinforcing its best-in-class potential in acromegaly following recent U.S. and E.U. approvals
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Crinetics Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. Were here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure were solving real problems for them. And we build value in... Read More
